Sodium-glucose Co-Transporter-2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors on Major Liver Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
DIABETES OBESITY & METABOLISM（2024）
关键词
cirrhosis,DPP4i,hepatocellular carcinoma,metabolic dysfunction-associated steatotic liver disease,SGLT2i,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要